Episode 208: A CEO's arrest, Pfizer's big deal, & Covid on the rise
The Readout Loud
00:00
Is It Just Roche?
There was a huge debate argument on kind of wall street amongst helcare investors and analysts. The final verdict on this class of therapes has yet to be written. And is it just roch? I mean, there're a lot of other companies focused on this two right? Oh, yes. You've got glaxo smith cline, you've got gilead, who did a big partnership with arcis around there ticet compound, compugin. There's a bunch of companies, a that murk has got one.
Transcript
Play full episode
